PP191 IMPACT OF FISH OIL-BASED EMULSION OR MCT/LCT EMULSION ON PARENTERAL NUTRITION ASSICIATED CHOLESTASIS IN CHILDREN WITH SHORT BOWEL SYNDROME

2010 ◽  
Vol 5 (2) ◽  
pp. 97-98
Author(s):  
J. Ksiazyk ◽  
E. Nowicka ◽  
M. Krzewicka ◽  
A. Zyla ◽  
K. Popinska
2011 ◽  
Vol 31 (5) ◽  
pp. 503-509 ◽  
Author(s):  
Emma M Tillman ◽  
Catherine M Crill ◽  
Dennis D Black ◽  
Emily B Hak ◽  
Linda F Lazar ◽  
...  

2012 ◽  
Vol 26 (5) ◽  
pp. 277-280 ◽  
Author(s):  
Ana MGA Sant’Anna ◽  
Eyad Altamimi ◽  
Rose-Frances Clause ◽  
Joanne Saab ◽  
Heather Mileski ◽  
...  

OBJECTIVE: To describe the authors’ experience with the implementation of a multidisciplinary approach and use of fish oil emulsion (FOE) in the management of infants with short bowel syndrome (SBS) and parenteral nutrition-associated liver disease (PNALD).METHODS: Between August 2006 and June 2009, four cases of SBS and severe PNALD were managed by the team using specifically developed protocols. The FOE was initiated if serum direct bilirubin levels were ≥100 μmol/L. To quantify the degree of exposure to high serum direct bilirubin levels over time, the area under the curve (AUC) for each patient was calculated before and after initiation of FOE. Linear regression analyses were performed to evaluate correlations between the AUC, duration of cholestasis and initiation of FOE.RESULTS: All patients survived and no complications were observed during the study period. After the first patient, FOE was initiated progressively earlier, but poor correlation between the AUC before and after its introduction was observed (r2=0.41924). However, there was strong correlation between the duration of PNALD before FOE initiation and time to resolution (r2=0.72133): the earlier the FOE was initiated, the shorter the time to resolution.CONCLUSION: The authors report a positive experience with the implementation of a multidisciplinary approach and the use of FOE in infants with SBS and severe PNALD. The earlier the FOE was initiated during the cholestatic process, the shorter the time to resolution. The present study is a hypothesis generator, raising the question of whether an earlier introduction of this particular therapy can effectively shorten the cholestasis process in these patients.


2010 ◽  
Vol 25 (2) ◽  
pp. 199-204 ◽  
Author(s):  
Michael D. Rollins ◽  
Eric R. Scaife ◽  
W. Daniel Jackson ◽  
Rebecka L. Meyers ◽  
Cecilia W. Mulroy ◽  
...  

PEDIATRICS ◽  
2006 ◽  
Vol 118 (1) ◽  
pp. e197-e201 ◽  
Author(s):  
K. M. Gura ◽  
C. P. Duggan ◽  
S. B. Collier ◽  
R. W. Jennings ◽  
J. Folkman ◽  
...  

2008 ◽  
Vol 43 (6) ◽  
pp. 1191-1195 ◽  
Author(s):  
George Ekema ◽  
Diego Falchetti ◽  
Giovanni Boroni ◽  
Anna Rita Tanca ◽  
Cristian Altana ◽  
...  

2020 ◽  
Vol 2 (4) ◽  
Author(s):  
Zeinab Bakhshi ◽  
Siddhant Yadav ◽  
Bradley R Salonen ◽  
Sara L Bonnes ◽  
Jithinraj Edakkanambeth Varayil ◽  
...  

Abstract Background We sought to estimate the incidence of home parenteral nutrition (HPN) use in a population-based cohort of patients with Crohn disease (CD), and to assess clinical outcomes and complications associated with HPN. Methods We used the Rochester Epidemiology Project (REP) to identify residents of Olmsted County, who were diagnosed with CD between 1970 and 2011, and required HPN. Results Fourteen out of 429 patients (3.3%) with CD received HPN (86% female). Eleven patients (79%) had moderate–severe CD and 12 patients (86%) had fistulizing disease. Thirteen patients (93%) underwent surgery, primarily due to obstruction. Among CD incidence cases, the cumulative incidence of HPN from the date of CD diagnosis was 0% at 1 year, 0.5% at 5 years, 0.8% at 10 years, and 2.4% at 20 years. Indications for HPN included short bowel syndrome in 64%, malnutrition in 29%, and bowel rest in 21%. The median duration of HPN was 2.5 years. There was an average weight gain of 1.2 kg at 6 months, an average weight loss of 1.4 kg at 1 year, and a further weight loss of 2.2 kg at 2 years from the start of HPN. Patients were hospitalized a mean of 5 times after the start of HPN, mainly due to catheter-related bloodstream infections and thrombosis. Conclusions Less than 4% of patients with CD need HPN. Most have moderate to severe disease with short bowel syndrome or malnutrition. Possible reasons for the patients’ weight loss could be noncompliance, and increased metabolic needs because of active disease.


2003 ◽  
Vol 124 (2) ◽  
pp. 293-302 ◽  
Author(s):  
David Seguy ◽  
Kouroche Vahedi ◽  
Nathalie Kapel ◽  
Jean–Claude Souberbielle ◽  
Bernard Messing

Sign in / Sign up

Export Citation Format

Share Document